Area of research
Otorhinolaryngology · Cancer Research
Research interest
Research focused on Nuclear medicine and Head and neck cancer, with related work in Radiation therapy, CXCR4, Pembrolizumab. Notable publications include 'Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer', 'Prognostic value of dynamic hypoxia PET in head and neck cancer: Results from a planned interim analysis of a randomized phase II hypoxia-image guided dose escalation trial', and 'Prospective Evaluation of a Tumor Control Probability Model Based on Dynamic 18 F-FMISO PET for Head and Neck Cancer Radiotherapy'.
Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer
TOFIMS mass spectrometry-based immunopeptidomics refines tumor antigen identification
Prospective Evaluation of a Tumor Control Probability Model Based on Dynamic <sup>18</sup>F-FMISO PET for Head and Neck Cancer Radiotherapy
Prognostic value of dynamic hypoxia PET in head and neck cancer: Results from a planned interim analysis of a randomized phase II hypoxia-image guided dose escalation trial
SDF-1/CXCR4 expression is an independent negative prognostic biomarker in patients with head and neck cancer after primary radiochemotherapy
Geometric analysis of loco-regional recurrences in relation to pre-treatment hypoxia in patients with head and neck cancer
Overlap of highly FDG-avid and FMISO hypoxic tumor subvolumes in patients with head and neck cancer
SDF-1/CXCR4 expression in head and neck cancer and outcome after postoperative radiochemotherapy
Robustness of quantitative hypoxia PET image analysis for predicting local tumor control
A case of recurrent respiratory papillomatosis with malignant transformation, HPV11 DNAemia, high L1 antibody titre and a fatal papillary endocardial lesion